1255 related articles for article (PubMed ID: 27884163)
1. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.
Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH
Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-κB signaling pathway.
Jian M; Kwan JS; Bunting M; Ng RC; Chan KH
J Neuroinflammation; 2019 May; 16(1):110. PubMed ID: 31128596
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer's disease.
Ali T; Rehman SU; Khan A; Badshah H; Abid NB; Kim MW; Jo MH; Chung SS; Lee HG; Rutten BPF; Kim MO
Mol Neurodegener; 2021 Apr; 16(1):23. PubMed ID: 33849621
[TBL] [Abstract][Full Text] [Related]
4. AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
Liu B; Liu J; Wang JG; Liu CL; Yan HJ
Exp Neurol; 2020 May; 327():113249. PubMed ID: 32070713
[TBL] [Abstract][Full Text] [Related]
5. Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer's disease mouse model.
Ng RC; Jian M; Ma OK; Bunting M; Kwan JS; Zhou GJ; Senthilkumar K; Iyaswamy A; Chan PK; Li M; Leung KM; Kumar Durairajan SS; Lam KS; Chu LW; Festenstein R; Chung SK; Chan KH
Mol Psychiatry; 2021 Oct; 26(10):5669-5689. PubMed ID: 32132650
[TBL] [Abstract][Full Text] [Related]
6. AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice.
Khandelwal M; Manglani K; Upadhyay P; Azad M; Gupta S
Neurobiol Dis; 2022 Nov; 174():105876. PubMed ID: 36162737
[TBL] [Abstract][Full Text] [Related]
7. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
Wang C; Chang Y; Zhu J; Wu Y; Jiang X; Zheng S; Li G; Ma R
Exp Neurol; 2023 May; 363():114355. PubMed ID: 36868546
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain.
Hahm JR; Jo MH; Ullah R; Kim MW; Kim MO
Cells; 2020 Jan; 9(1):. PubMed ID: 31963819
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability?
Waragai M; Ho G; Takamatsu Y; Wada R; Sugama S; Takenouchi T; Masliah E; Hashimoto M
Front Endocrinol (Lausanne); 2020; 11():108. PubMed ID: 32194507
[TBL] [Abstract][Full Text] [Related]
10. High-Intensity Interval Training Ameliorates Molecular Changes in the Hippocampus of Male Rats with the Diabetic Brain: the Role of Adiponectin.
Khoramipour K; Bejeshk MA; Rajizadeh MA; Najafipour H; Dehghan P; Farahmand F
Mol Neurobiol; 2023 Jun; 60(6):3486-3495. PubMed ID: 36877358
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
[TBL] [Abstract][Full Text] [Related]
13. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer's disease lesion in hippocampus of rats with type 2 diabetes mellitus.
Sun Q; Wei LL; Zhang M; Li TX; Yang C; Deng SP; Zeng QC
Int J Neurosci; 2019 Feb; 129(2):179-188. PubMed ID: 29962282
[TBL] [Abstract][Full Text] [Related]
15. Chikusetsu Saponin IVa Ameliorates Cerebral Ischemia Reperfusion Injury in Diabetic Mice via Adiponectin-Mediated AMPK/GSK-3β Pathway In Vivo and In Vitro.
Duan J; Yin Y; Cui J; Yan J; Zhu Y; Guan Y; Wei G; Weng Y; Wu X; Guo C; Wang Y; Xi M; Wen A
Mol Neurobiol; 2016 Jan; 53(1):728-743. PubMed ID: 25636683
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
17. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
[TBL] [Abstract][Full Text] [Related]
18. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice.
Yan XD; Qu XS; Yin J; Qiao J; Zhang J; Qi JS; Wu MN
J Alzheimers Dis; 2022; 85(1):343-357. PubMed ID: 34806605
[TBL] [Abstract][Full Text] [Related]
20. Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease.
Waragai M; Adame A; Trinh I; Sekiyama K; Takamatsu Y; Une K; Masliah E; Hashimoto M
J Alzheimers Dis; 2016 Apr; 52(4):1453-9. PubMed ID: 27079710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
